These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28441702)

  • 1. Pricing in the Market for Anticancer Drugs.
    Howard DH; Bach PB; Berndt ER; Conti RM
    J Econ Perspect; 2015; 29(1):139-62. PubMed ID: 28441702
    [No Abstract]   [Full Text] [Related]  

  • 2. Market spiral pricing of cancer drugs.
    Light DW; Kantarjian H
    Cancer; 2013 Nov; 119(22):3900-2. PubMed ID: 24002792
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic grand rounds: potential effects of the new medicare drug benefit on pricing for psychotropic medications.
    Huskamp HA; Shinogle JA
    Psychiatr Serv; 2005 Sep; 56(9):1056-8. PubMed ID: 16148317
    [No Abstract]   [Full Text] [Related]  

  • 4. Indication-specific Drug Pricing - Simple in Theory, Complex in Reality.
    Kwon S
    Manag Care; 2018 May; 27(5):23-25. PubMed ID: 29763404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription drug prices: why do some pay more than others do?
    Frank RG
    Health Aff (Millwood); 2001; 20(2):115-28. PubMed ID: 11260933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowering the High Cost of Cancer Drugs--II.
    Messori A; Fadda V; Trippoli S
    Mayo Clin Proc; 2016 Mar; 91(3):397-9. PubMed ID: 26944244
    [No Abstract]   [Full Text] [Related]  

  • 7. Affordable prescription drugs--state and federal action.
    Ohio Nurses Rev; 2003 Aug; 78(7):4. PubMed ID: 15134064
    [No Abstract]   [Full Text] [Related]  

  • 8. Prescription drug pricing: the consumer perspective.
    Searing A
    N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625
    [No Abstract]   [Full Text] [Related]  

  • 9. States on the Front Line: Addressing America's Drug Pricing Problem.
    Riley T; Lanford S
    J Leg Med; 2019; 39(2):81-93. PubMed ID: 31503529
    [No Abstract]   [Full Text] [Related]  

  • 10. Trajectories of Injectable Cancer Drug Costs After Launch in the United States.
    Gordon N; Stemmer SM; Greenberg D; Goldstein DA
    J Clin Oncol; 2018 Feb; 36(4):319-325. PubMed ID: 29016226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pricing increases for cancer drugs sparks investigation.
    Venkatesan P
    Lancet Oncol; 2017 Jul; 18(7):e372. PubMed ID: 28552213
    [No Abstract]   [Full Text] [Related]  

  • 12. Government commitment and regulation of prescription drugs.
    Frank RG
    Health Aff (Millwood); 2003; 22(3):46-8. PubMed ID: 12757271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Market Access Agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts.
    Jarosławski S; Toumi M
    BMC Health Serv Res; 2011 Oct; 11():259. PubMed ID: 21982545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Market watch: Upcoming catalysts in Q1 2015.
    Uribe A
    Nat Rev Drug Discov; 2015 Jan; 14(1):9. PubMed ID: 25503330
    [No Abstract]   [Full Text] [Related]  

  • 15. Unexpected "donut hole" raises concerns that patients will fail to fill needed prescriptions.
    Howard-Ruben J
    ONS News; 2006 Dec; 21(12):10-1. PubMed ID: 17193936
    [No Abstract]   [Full Text] [Related]  

  • 16. Why are cancer drugs so expensive in the United States, and what are the solutions?
    Kantarjian H; Rajkumar SV
    Mayo Clin Proc; 2015 Apr; 90(4):500-4. PubMed ID: 25792242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Realigning incentives for developing and pricing new anticancer treatments.
    Howard DH
    JAMA; 2011 Jun; 305(22):2347-8. PubMed ID: 21642689
    [No Abstract]   [Full Text] [Related]  

  • 18. Value-based differential pricing: efficient prices for drugs in a global context.
    Danzon P; Towse A; Mestre-Ferrandiz J
    Health Econ; 2015 Mar; 24(3):294-301. PubMed ID: 24327269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The state and consequences of dermatology drug prices in the United States.
    Albrecht J; Lebwohl M; Asgari MM; Bennett DD; Cook A; Evans CC; Green LJ; Hodge JA; Kourosh AS; Maloney ME; Howard LM; Olsen EA; Rosenberg SP; Rubin A; Stough DB; Taylor SC; Brod BA
    J Am Acad Dermatol; 2016 Sep; 75(3):603-605. PubMed ID: 27423978
    [No Abstract]   [Full Text] [Related]  

  • 20. Tips for preparing for a 340B integrity audit.
    Wood W; Jorgenson J; Kelly W
    Healthc Financ Manage; 2012 Dec; 66(12):50-2. PubMed ID: 23252228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.